Notify me when Wildcat Capital Management, LLC files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| VICP | Vicapsys Life Sciences, Inc. | Common Stock, $0.001 par value | 19% | $30,352,940 | 6,070,588 | Wildcat Capital Management, LLC | 20 Apr 2020 | ||
| SLXN | Silexion Therapeutics Corp | Ordinary Shares, par value $0.0009 per share | 1.3% | $110,025 | 113,428 | Wildcat Capital Management, LLC | 26 Jun 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|